All Categories / Pharmacology & Pharmacy

Pharmacology & Pharmacy Journals

Browse 165 journals in Pharmacology & Pharmacy. Click on any journal to view complete submission guidelines, formatting requirements, and more.

View top Pharmacology & Pharmacy journals by impact factor
NR
Nature Reviews Drug Discovery

NATURE PORTFOLIO

IF: 101.8
Q1
Hybrid
DR
Drug Resistance Updates

Elsevier BV

IF: 21.7
Q1
Hybrid
TI
Trends In Pharmacological Sciences

Elsevier BV

IF: 19.9
Q1
Hybrid
AD
Advanced Drug Delivery Reviews

Elsevier BV

IF: 17.6
Q1
Hybrid
PR
Pharmacological Reviews

American Society for Pharmacology and Experimental Therapeutics

IF: 17.3
Q1
Hybrid
AP
Acta Pharmaceutica Sinica B

Elsevier BV

IF: 14.6
Q1
Open
Dr
Drugs

Adis, Springer Healthcare

IF: 14.4
Q1
Hybrid
AR
Annual Review Of Pharmacology And Toxicology

ANNUAL REVIEWS

IF: 13.1
Q1
Open
P&
Pharmacology & Therapeutics

Elsevier BV

IF: 12.5
Q1
Hybrid
AJ
Asian Journal Of Pharmaceutical Sciences

Elsevier BV

IF: 11.9
Q1
Hybrid
MR
Medicinal Research Reviews

WILEY

IF: 11.6
Q1
Hybrid
JO
Journal Of Controlled Release

Elsevier BV

IF: 11.5
Q1
Hybrid
PR
Pharmacological Research

Elsevier BV

IF: 10.5
Q1
Open
JO
Journal Of Pharmaceutical Analysis

Elsevier BV

IF: 8.9
Q1
Open
AP
Acta Pharmacologica Sinica

Springer Nature

IF: 8.4
Q1
Hybrid
Ph
Phytomedicine

Elsevier BV

IF: 8.3
Q1
Hybrid
DD
Drug Delivery

Taylor & Francis

IF: 8.1
Q1
Hybrid
B&
Biomedicine & Pharmacotherapy

Elsevier BV

IF: 7.5
Q1
Open
DD
Drug Discovery Today

Elsevier BV

IF: 7.5
Q1
Hybrid
AO
Archives Of Pharmacal Research

Springer Nature

IF: 7.5
Q1
Hybrid
CD
Cns Drugs

Adis, Springer Healthcare

IF: 7.4
Q1
Hybrid
Ne
Neuropsychopharmacology

Springer Nature

IF: 7.1
Q1
Hybrid
Ne
Neurotherapeutics

Springer Science+Business Media

IF: 6.9
Q1
Open
Bi
Biodrugs

Adis, Springer Healthcare

IF: 6.9
Q1
Hybrid
AP
Alimentary Pharmacology & Therapeutics

WILEY

IF: 6.7
Q1
Hybrid
EN
European Neuropsychopharmacology

Elsevier BV

IF: 6.7
Q1
Hybrid
IJ
International Journal Of Nanomedicine

Dove Medical Press

IF: 6.5
Q1
Hybrid
IJ
International Journal Of Pharmaceutics-x

Elsevier BV

IF: 6.4
Q1
Open
PR
Phytotherapy Research

WILEY

IF: 6.3
Q1
Hybrid
EH
European Heart Journal-cardiovascular Pharmacotherapy

Oxford University Press

IF: 6.1
Q1
Open
CM
Chinese Medicine

BioMed Central

IF: 5.7
Q1
Open
BP
Biochemical Pharmacology

Elsevier BV

IF: 5.6
Q1
Hybrid
CP
Clinical Pharmacology & Therapeutics

WILEY

IF: 5.5
Q1
Hybrid
JO
Journal Of Psychopharmacology

SAGE Publishing

IF: 5.5
Q1
Hybrid
DD
Drug Delivery And Translational Research

Springer Science+Business Media

IF: 5.5
Q1
Hybrid
Ph
Pharmaceutics

Multidisciplinary Digital Publishing Institute

IF: 5.5
Q1
Open
JO
Journal Of Ethnopharmacology

Elsevier BV

IF: 5.4
Q1
Hybrid
CI
Chemico-biological Interactions

Elsevier BV

IF: 5.4
Q1
Hybrid
EO
Expert Opinion On Drug Delivery

Taylor & Francis

IF: 5.4
Q1
Closed
MD
Marine Drugs

Multidisciplinary Digital Publishing Institute

IF: 5.4
Q1
Open
CN
Current Neuropharmacology

Bentham Science Publishers

IF: 5.3
Q1
Hybrid
IJ
International Journal Of Pharmaceutics

Elsevier BV

IF: 5.2
Q1
Hybrid
LS
Life Sciences

Elsevier BV

IF: 5.1
Q1
Hybrid
JO
Journal Of Pharmaceutical Investigation

Springer Science+Business Media

IF: 5.1
Q1
Hybrid
DD
Drug Design Development And Therapy

Dove Medical Press

IF: 5.1
Q1
Hybrid
CN
Cns Neuroscience & Therapeutics

WILEY

IF: 5
Q1
Open
JO
Journal Of Drug Delivery Science And Technology

Elsevier BV

IF: 4.9
Q1
Hybrid
EO
Expert Opinion On Drug Discovery

Taylor & Francis

IF: 4.9
Q1
Closed
CJ
Chinese Journal Of Natural Medicines

Elsevier BV

IF: 4.9
Q1
Open
PB
Pharmaceutical Biology

Taylor & Francis

IF: 4.8
Q1
Open
FI
Frontiers In Pharmacology

Frontiers Media

IF: 4.8
Q1
Open
Ph
Pharmaceuticals

Multidisciplinary Digital Publishing Institute

IF: 4.8
Q1
Open
II
International Immunopharmacology

Elsevier BV

IF: 4.7
Q2
Hybrid
EJ
European Journal Of Pharmacology

Elsevier BV

IF: 4.7
Q1
Hybrid
EJ
European Journal Of Pharmaceutical Sciences

Elsevier BV

IF: 4.7
Q1
Open
An
Antibiotics-basel

Multidisciplinary Digital Publishing Institute

IF: 4.6
Q1
Open
Ne
Neuropharmacology

Elsevier BV

IF: 4.6
Q1
Hybrid
To
Toxicology

Elsevier BV

IF: 4.6
Q1
Hybrid
IJ
International Journal Of Antimicrobial Agents

Elsevier BV

IF: 4.6
Q1
Hybrid
Ph
Pharmacoeconomics

Adis, Springer Healthcare

IF: 4.6
Q1
Hybrid
EO
Expert Opinion On Therapeutic Patents

Taylor & Francis

IF: 4.6
Q1
Closed
JO
Journal Of Clinical Lipidology

Elsevier BV

IF: 4.6
Q1
Hybrid
AA
Antimicrobial Agents And Chemotherapy

American Society for Microbiology

IF: 4.5
Q1
Hybrid
MP
Molecular Pharmaceutics

American Chemical Society

IF: 4.5
Q2
Hybrid
PM
Pharmaceutical Medicine

Adis, Springer Healthcare

IF: 4.5
Q1
Hybrid
EO
Expert Opinion On Therapeutic Targets

Taylor & Francis

IF: 4.4
Q1
Closed
MD
Molecular Diagnosis & Therapy

Adis, Springer Healthcare

IF: 4.4
Q1
Hybrid
PR
Pharmaceutical Research

Springer Science+Business Media

IF: 4.3
Q1
Hybrid
EJ
European Journal Of Pharmaceutics And Biopharmaceutics

Elsevier BV

IF: 4.3
Q1
Hybrid
JO
Journal Of Liposome Research

Taylor & Francis

IF: 4.3
Q1
Closed
AA
Admet And Dmpk

International Association of Physical Chemists (IAPC)

IF: 4.3
Q1
Open
JO
Journal Of Pharmacy And Pharmaceutical Sciences

Canadian Society for Pharmaceutical Sciences

IF: 4.3
Q1
Open
ET
Environmental Toxicology And Pharmacology

Elsevier BV

IF: 4.2
Q1
Hybrid
CO
Current Opinion In Pharmacology

Elsevier BV

IF: 4.2
Q1
Hybrid
DD
Drug Development Research

WILEY

IF: 4.2
Q1
Hybrid
AP
Australian Prescriber

NPS MedicineWise

IF: 4.2
Q1
Open
EO
Expert Opinion On Investigational Drugs

Taylor & Francis

IF: 4.1
Q1
Closed
AP
Advanced Pharmaceutical Bulletin

Tabriz University of Medical Sciences

IF: 4.1
Q1
Open
RP
Recent Patents On Anti-cancer Drug Discovery

Bentham Science Publishers

IF: 4.1
Q2
Open
AP
Aaps Pharmscitech

Springer Science+Business Media

IF: 4
Q1
Hybrid
DM
Drug Metabolism And Disposition

American Society for Pharmacology and Experimental Therapeutics

IF: 4
Q1
Hybrid
CP
Clinical Pharmacokinetics

Adis, Springer Healthcare

IF: 4
Q1
Hybrid
AR
Antiviral Research

Elsevier BV

IF: 4
Q1
Hybrid
AI
Advances In Therapy

Adis, Springer Healthcare

IF: 4
Q2
Hybrid
TA
Therapeutic Advances In Psychopharmacology

SAGE Publishing

IF: 4
Q1
Open
PI
Progress In Neuro-psychopharmacology & Biological Psychiatry

Elsevier BV

IF: 3.9
Q1
Hybrid
Ne
Neurotoxicology

Elsevier BV

IF: 3.9
Q2
Hybrid
JO
Journal Of Drug Targeting

Taylor & Francis

IF: 3.9
Q1
Hybrid
Bi
Biomedicines

Multidisciplinary Digital Publishing Institute

IF: 3.9
Q2
Open
JO
Journal Of Pharmaceutical Sciences

Elsevier BV

IF: 3.8
Q2
Hybrid
JO
Journal Of Pharmacology And Experimental Therapeutics

American Society for Pharmacology and Experimental Therapeutics

IF: 3.8
Q2
Hybrid
DS
Drug Safety

Adis, Springer Healthcare

IF: 3.8
Q2
Hybrid
PR
Pharmacological Reports

Elsevier BV

IF: 3.8
Q2
Hybrid
ER
Expert Review Of Anti-infective Therapy

Taylor & Francis

IF: 3.8
Q1
Hybrid
D&
Drugs & Aging

Adis, Springer Healthcare

IF: 3.8
Q2
Hybrid
DM
Drug Metabolism Reviews

Taylor & Francis

IF: 3.8
Q2
Closed
AJ
Aaps Journal

Springer Science+Business Media

IF: 3.7
Q2
Hybrid
IJ
International Journal Of Neuropsychopharmacology

University of Oxford

IF: 3.7
Q1
Hybrid
JO
Journal Of Ethnobiology And Ethnomedicine

BioMed Central

IF: 3.7
Q2
Open
AP
Acs Pharmacology & Translational Science

American Chemical Society

IF: 3.7
Q2
Hybrid
JO
Journal Of Antimicrobial Chemotherapy

Oxford University Press

IF: 3.6
Q2
Hybrid
JO
Journal Of Natural Products

American Chemical Society

IF: 3.6
Q2
Hybrid
CT
Clinical Therapeutics

Elsevier BV

IF: 3.6
Q2
Hybrid
AD
Archiv Der Pharmazie

WILEY

IF: 3.6
Q2
Hybrid
CM
Current Medicinal Chemistry

Bentham Science Publishers

IF: 3.5
Q2
Hybrid
RT
Regulatory Toxicology And Pharmacology

Elsevier BV

IF: 3.5
Q1
Hybrid
AJ
American Journal Of Pharmaceutical Education

Elsevier BV

IF: 3.5
Q2
Hybrid
VP
Vascular Pharmacology

Elsevier BV

IF: 3.5
Q2
Hybrid
JO
Journal Of Neuroimmune Pharmacology

Springer Science+Business Media

IF: 3.5
Q2
Hybrid
CA
Clinical And Experimental Hypertension

Informa

IF: 3.5
Q2
Open
TA
Toxicology And Applied Pharmacology

Elsevier BV

IF: 3.4
Q2
Hybrid
Ch
Chemmedchem

WILEY

IF: 3.4
Q2
Hybrid
SP
Saudi Pharmaceutical Journal

Elsevier BV

IF: 3.4
Q2
Open
Ph
Pharmacotherapy

WILEY

IF: 3.4
Q2
Hybrid
ER
Expert Review Of Neurotherapeutics

Taylor & Francis

IF: 3.4
Q2
Hybrid
EO
Expert Opinion On Drug Metabolism & Toxicology

Taylor & Francis

IF: 3.4
Q2
Hybrid
IJ
International Journal For Parasitology-drugs And Drug Resistance

Elsevier BV

IF: 3.4
Q2
Open
CT
Cardiovascular Therapeutics

WILEY

IF: 3.4
Q2
Hybrid
TA
Therapeutic Advances In Drug Safety

SAGE Publishing

IF: 3.4
Q2
Open
Ps
Psychopharmacology

Springer Science+Business Media

IF: 3.3
Q2
Hybrid
B&
Basic & Clinical Pharmacology & Toxicology

WILEY

IF: 3.3
Q2
Hybrid
PD
Pediatric Drugs

Adis, Springer Healthcare

IF: 3.3
Q1
Hybrid
JR
Jac-antimicrobial Resistance

Oxford University Press

IF: 3.3
Q2
Open
JO
Journal Of Pharmacy And Pharmacology

Oxford University Press

IF: 3.2
Q2
Hybrid
JO
Journal Of Global Antimicrobial Resistance

Elsevier BV

IF: 3.2
Q2
Open
IJ
International Journal Of Clinical Pharmacy

Springer Science+Business Media

IF: 3.2
Q2
Open
JO
Journal Of Microencapsulation

Taylor & Francis

IF: 3.2
Q2
Hybrid
B&
Biomolecules & Therapeutics

Korean Society of Applied Pharmacology

IF: 3.2
Q2
Closed
Ph
Pharmacology

Karger Publishers

IF: 3.2
Q2
Closed
SP
Skin Pharmacology And Physiology

Karger Publishers

IF: 3.2
Q1
Closed
WJ
World Journal Of Traditional Chinese Medicine

Medknow

IF: 3.2
Q2
Open
JO
Journal Of Pharmaceutical And Biomedical Analysis

Elsevier BV

IF: 3.1
Q2
Hybrid
NA
Naunyn-schmiedebergs Archives Of Pharmacology

Springer Science+Business Media

IF: 3.1
Q2
Hybrid
EO
Expert Opinion On Drug Safety

Taylor & Francis

IF: 3.1
Q2
Hybrid
CD
Cardiovascular Drugs And Therapy

Springer Science+Business Media

IF: 3.1
Q2
Hybrid
BJ
British Journal Of Clinical Pharmacology

WILEY

IF: 3
Q2
Hybrid
MP
Molecular Pharmacology

American Society for Pharmacology and Experimental Therapeutics

IF: 3
Q2
Hybrid
C&
Cpt-pharmacometrics & Systems Pharmacology

NATURE PORTFOLIO

IF: 3
Q2
Open
C&
CNS & Neurological Disorders - Drug Targets

Bentham Science Publishers

IF: 3
Q2
Open
ER
Expert Review Of Clinical Pharmacology

Taylor & Francis

IF: 3
Q2
Closed
Ch
Chirality

WILEY

IF: 3
Q2
Hybrid
CD
Current Drug Delivery

Bentham Science Publishers

IF: 3
Q2
Hybrid
IA
Immunopharmacology And Immunotoxicology

Taylor & Francis

IF: 3
Q3
Hybrid
AJ
American Journal Of Cardiovascular Drugs

Adis, Springer Healthcare

IF: 3
Q2
Hybrid
AI
Advances In Pharmacological And Pharmaceutical Sciences

Hindawi Publishing Corporation

IF: 3
Q2
Open
IA
Infection And Drug Resistance

Dove Medical Press

IF: 2.9
Q2
Open
Pe
Peptides

Elsevier BV

IF: 2.9
Q3
Hybrid
JO
Journal Of Pharmacological Sciences

Elsevier BV

IF: 2.9
Q2
Open
JO
Journal Of Managed Care & Specialty Pharmacy

AMCP

IF: 2.9
Q2
Open
Al
Alcohol

Elsevier BV

IF: 2.9
Q2
Hybrid
PJ
Pharmacogenomics Journal

Springer Nature

IF: 2.9
Q2
Hybrid
CM
Current Molecular Pharmacology

Bentham Science Publishers

IF: 2.9
Q2
Hybrid
CP
Current Pharmaceutical Design

Bentham Science Publishers

IF: 2.8
Q2
Hybrid
JO
Journal Of Clinical Psychopharmacology

LIPPINCOTT WILLIAMS & WILKINS

IF: 2.8
Q2
Hybrid
TA
Therapeutic Advances In Chronic Disease

SAGE Publishing

IF: 2.8
Q2
Open
JO
Journal Of Pharmacokinetics And Pharmacodynamics

Springer Science+Business Media

IF: 2.8
Q2
Hybrid
JO
Journal Of Cardiovascular Pharmacology And Therapeutics

SAGE Publishing

IF: 2.8
Q2
Hybrid
PP
Pulmonary Pharmacology & Therapeutics

Elsevier BV

IF: 2.8
Q2
Hybrid
DI
Drugs In Context

BioExcel Publishing Ltd

IF: 2.8
Q2
Open
PB
Pharmacology Biochemistry And Behavior

Elsevier BV

IF: 2.5
Q2
Hybrid
JO
Journal Of Pharmaceutical Policy And Practice

BioMed Central

IF: 2.5
Q2
Open
AT
Antiviral Therapy

SAGE Publishing

IF: 2.3
Q3
Open
JO
Journal Of Chemotherapy

Taylor & Francis

IF: 1.8
Q3
Hybrid
HR
Hiv Research & Clinical Practice

Taylor & Francis

IF: 1.8
Q3
Open
JO
Journal Of Infection And Chemotherapy

Elsevier BV

IF: 1.5
Q4
Hybrid
Related Categories
Neurosciences (177)
Oncology (170)
Public, Environmental & Occupational Health (136)
Clinical Neurology (127)
Infectious Diseases (116)
Immunology (110)
Endocrinology & Metabolism (105)
Psychiatry (102)
Preparing a Manuscript?

Use our Journal Finder to search and filter across all specialties by impact factor, quartile, and more.

Try Livewrite to write, edit, cite, and automatically format your manuscript for any journal - all directly inside Microsoft Word.